e-ISSN:2320-1215 p-ISSN: 2322-0112

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

2020 Announcement of Pharmaceutical research and Innovations in Pharma Industry Conference

Alexander Seifalian

CEO and Professor, Nanotechnology & Regenerative Medicine, London Bio Science Innovation Centre, United Kingdom, E-mail: a.seifalian@gmail.com

Visit for more related articles at Research & Reviews in Pharmacy and Pharmaceutical Sciences

2020-Announcement of Pharma Research

Conference Series LLC Ltd is pleased to announce our 3rd International Conference on Pharmaceutical Research & Innovations in Pharma Industry during March 27-28, 2020 at Barcelona, Spain.

Pharma Research 2020 aims to provide a platform where the key strategic objective of this meeting is to communicate science and medical research between academia, and industry. Through inspiring sessions and whims of networking, you will learn to be even more audacious and bold than you are now and free to grow your mind, grow your business, and grow your bottom line. We can relieve you of the time and resource-draining elements of the events that you plan to hold. . Poster and oral presentations, and thesis presentations will be included in the Conference Program.

We can relieve you of the time and resource-draining elements of the events that you plan to hold. This conference is intended to deliver a miscellaneous and current education that will keep medical professionals up to date with the latest methodologies, strategies and the present update in the field of Pharmaceutical Research.

The goal of organizing the Pharmaceutical Research 2020 is to provide exposure to technologies and to deliver information about research work proceeding on Pharmaceutical Research


Pharmaceutical Research is used for developing a new medicine it will take nearly 10-15 years and on average and costs an average of $2.6 billion. In discovery procedure comprises the initial stages of research, which are intended to recognize an investigational drug and perform primary tests in the lab. This first stage of the process takes three to six years. By the end, investigators hope to identify a capable drug aspirant to further study in the lab and in animal models, and then in people. These developments offer great ability, but also add complexity to the R&D process. In order to ensure the safety and efficacy of personalized therapies that are used along with diagnostics, clinical trial protocols must be improved and increased.

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices

Contact Person:
Jessie Rose | Program Manager
Pharma Research 2020
47Churchfield Road, W3 6AY, London
Tel: 44-8000148923, 1-7025085201
Email- pharmaresearch@eventsupporting.org